Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2025-12-25 @ 7:05 PM
NCT ID:
NCT00999804
Group ID:
EG001
Title:
12-week Arm
Description:
Participants will receive 12-weeks of lapatinib plus trastuzumab. Participants who are estrogen receptor (ER) and/or progesterone receptor (PR) positive will also receive endocrine therapy.
Lapatinib: 1000 mg by mouth daily
Letrozole: 2.5 mg by mouth daily (for hormone receptor positive participants only)
Trastuzumab: 6 mg/kg intravenously, every 3 weeks
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
1
Serious Number At Risk:
43
Other Number Affected:
26
Other Number At Risk:
43
Study:
NCT00999804
Results Section:
NCT00999804
Adverse Events Module:
NCT00999804